Related Experiment Videos

[Ulcerative colitis caused by Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome]

Insights

Histoplasma capsulatum can cause ulcerative colitis in individuals with acquired immune deficiency syndrome (AIDS). Long-term antifungal therapy is recommended for AIDS patients with histoplasmosis to prevent relapses.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Acquired immune deficiency syndrome (AIDS) compromises the immune system, increasing susceptibility to opportunistic infections.
  • Ulcerative colitis is a chronic inflammatory bowel disease with various potential etiologies.
  • Histoplasma capsulatum is a fungus that can cause disseminated infections in immunocompromised individuals.

Observation:

  • A previously healthy 35-year-old French geologist with AIDS presented with ulcerative colitis.
  • Colonic biopsies revealed Histoplasma capsulatum via Gomori-Grocott and PAS stains, and indirect immunofluorescence.
  • LAV antibody testing was positive, and T-lymphocyte analysis showed significantly reduced OKT4 cells (10/mm3) with a low OKT4/OKT8 ratio (0.16).

Findings:

  • The case demonstrates a rare presentation of ulcerative colitis caused by Histoplasma capsulatum in an AIDS patient.
  • Diagnostic confirmation relied on histopathological examination of colonic biopsies and serological markers for HIV (LAV antibody).
  • Severe T-cell depletion (OKT4) was noted, consistent with advanced HIV infection.

Implications:

  • Histoplasmosis should be considered in the differential diagnosis of ulcerative colitis, particularly in patients with relevant epidemiological risk factors and immunosuppression.
  • Patients with AIDS and histoplasmosis are at high risk for treatment relapses after discontinuation of therapy.
  • Indefinite suppressive therapy with imidazole antifungals is likely necessary to manage disseminated histoplasmosis in AIDS patients and prevent recurrence.

Related Concept Videos